We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Economical Method of Gene Silencing

By Biotechdaily staff writers
Posted on 27 Jan 2004
An alternative, more efficient way to accomplish the specific inhibition of gene functions by means of RNAs has been developed.

Currently, small interfering (si) RNAs are the method of choice to "knockdown” the function of particular genes, thereby offering clues about which genes are responsible for the expression of a particular bodily function. More...
However, the application of these molecules has proven to be inefficient, their chemical synthesis is very expensive, and their use in high-throughput screening experiments is uneconomical. An alternative method of gene silencing has been developed by the nonprofit German Resource Center for Genome Research (RZPD, Berlin, Germany).

To use this method, RZPD first manufactured and verified gene-specific products for some 36,000 Unigene Clusters. These were represented by polymerase chain reaction (PCR) products, which were amplified using two gene-specific primers per gene, avoiding repetitive or conserved sequences. Then T7 promoters were added to convert these double stranded (ds)DNAs into dsRNAs by in vitro transcription. These long dsRNA molecules can be cut by Dicer or RNaseII (exonuclease II) into functional siRNAs. The final products are potent tools for the specific knockdown of genes, often superior to synthesized siRNA oligos.

RZPD is a service center for genomics and proteomics research. Based on one of the largest clone collections worldwide, it provides high quality research material, high throughput technology, and automation solutions for academic institutions as well as for industry. A wide variety of materials and services are available. No intellectual property is claimed by RZPD for results derived from the use of its material.




Related Links:
RZPD

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.